Literature DB >> 28835493

PrP P102L and Nearby Lysine Mutations Promote Spontaneous In Vitro Formation of Transmissible Prions.

Allison Kraus1, Gregory J Raymond1, Brent Race1, Katrina J Campbell1, Andrew G Hughson1, Kelsie J Anson1, Lynne D Raymond1, Byron Caughey2.   

Abstract

Accumulation of fibrillar protein aggregates is a hallmark of many diseases. While numerous proteins form fibrils by prion-like seeded polymerization in vitro, only some are transmissible and pathogenic in vivo To probe the structural features that confer transmissibility to prion protein (PrP) fibrils, we have analyzed synthetic PrP amyloids with or without the human prion disease-associated P102L mutation. The formation of infectious prions from PrP molecules in vitro has required cofactors and/or unphysiological denaturing conditions. Here, we demonstrate that, under physiologically compatible conditions without cofactors, the P102L mutation in recombinant hamster PrP promoted prion formation when seeded by minute amounts of scrapie prions in vitro Surprisingly, combination of the P102L mutation with charge-neutralizing substitutions of four nearby lysines promoted spontaneous prion formation. When inoculated into hamsters, both of these types of synthetic prions initiated substantial accumulation of prion seeding activity and protease-resistant PrP without transmissible spongiform encephalopathy (TSE) clinical signs or notable glial activation. Our evidence suggests that PrP's centrally located proline and lysine residues act as conformational switches in the in vitro formation of transmissible PrP amyloids.IMPORTANCE Many diseases involve the damaging accumulation of specific misfolded proteins in thread-like aggregates. These threads (fibrils) are capable of growing on the ends by seeding the refolding and incorporation of the normal form of the given protein. In many cases such aggregates can be infectious and propagate like prions when transmitted from one individual host to another. Some transmitted aggregates can cause fatal disease, as with human iatrogenic prion diseases, while other aggregates appear to be relatively innocuous. The factors that distinguish infectious and pathogenic protein aggregates from more innocuous ones are poorly understood. Here we have compared the combined effects of prion seeding and mutations of prion protein (PrP) on the structure and transmission properties of synthetic PrP aggregates. Our results highlight the influence of specific sequence features in the normally unstructured region of PrP that influence the infectious and neuropathogenic properties of PrP-derived aggregates.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  GSS; RT-QuIC; conformational switches; lysine; prion protein; prions; proline; protein misfolding; transmissibility

Mesh:

Substances:

Year:  2017        PMID: 28835493      PMCID: PMC5640842          DOI: 10.1128/JVI.01276-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Lower specific infectivity of protease-resistant prion protein generated in cell-free reactions.

Authors:  Mikael Klingeborn; Brent Race; Kimberly D Meade-White; Bruce Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

2.  Stabilization of a prion strain of synthetic origin requires multiple serial passages.

Authors:  Natallia Makarava; Gabor G Kovacs; Regina Savtchenko; Irina Alexeeva; Herbert Budka; Robert G Rohwer; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

3.  Requirements for mutant and wild-type prion protein misfolding in vitro.

Authors:  Geoffrey P Noble; Daniel J Walsh; Michael B Miller; Walker S Jackson; Surachai Supattapone
Journal:  Biochemistry       Date:  2015-01-22       Impact factor: 3.162

4.  Generating a prion with bacterially expressed recombinant prion protein.

Authors:  Fei Wang; Xinhe Wang; Chong-Gang Yuan; Jiyan Ma
Journal:  Science       Date:  2010-01-28       Impact factor: 47.728

5.  Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.

Authors:  Bruce Chesebro; Brent Race; Kimberly Meade-White; Rachel Lacasse; Richard Race; Mikael Klingeborn; James Striebel; David Dorward; Gillian McGovern; Martin Jeffrey
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

6.  Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.

Authors:  Patrick Tremblay; Haydn L Ball; Kiyotoshi Kaneko; Darlene Groth; Ramanujan S Hegde; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner; Jiri G Safar
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  De novo generation of infectious prions with bacterially expressed recombinant prion protein.

Authors:  Zhihong Zhang; Yi Zhang; Fei Wang; Xinhe Wang; Yuanyuan Xu; Huaiyi Yang; Guohua Yu; Chonggang Yuan; Jiyan Ma
Journal:  FASEB J       Date:  2013-08-22       Impact factor: 5.191

8.  Self-propagating, protease-resistant, recombinant prion protein conformers with or without in vivo pathogenicity.

Authors:  Fei Wang; Xinhe Wang; Christina D Orrú; Bradley R Groveman; Krystyna Surewicz; Romany Abskharon; Morikazu Imamura; Takashi Yokoyama; Yong-Sun Kim; Kayla J Vander Stel; Kumar Sinniah; Suzette A Priola; Witold K Surewicz; Byron Caughey; Jiyan Ma
Journal:  PLoS Pathog       Date:  2017-07-12       Impact factor: 6.823

9.  Protease-sensitive synthetic prions.

Authors:  David W Colby; Rachel Wain; Ilia V Baskakov; Giuseppe Legname; Christina G Palmer; Hoang-Oanh B Nguyen; Azucena Lemus; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  PLoS Pathog       Date:  2010-01-22       Impact factor: 6.823

10.  Factors That Improve RT-QuIC Detection of Prion Seeding Activity.

Authors:  Christina D Orrú; Andrew G Hughson; Bradley R Groveman; Katrina J Campbell; Kelsie J Anson; Matteo Manca; Allison Kraus; Byron Caughey
Journal:  Viruses       Date:  2016-05-23       Impact factor: 5.048

View more
  6 in total

1.  The G127V variant of the prion protein interferes with dimer formation in vitro but not in cellulo.

Authors:  Sudheer Babu Sangeetham; Anna Dorothee Engelke; Jörg Tatzelt; Ervin Welker; Elfrieda Fodor; Sarah Laura Krausz
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

Review 2.  Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases.

Authors:  Eva Bagyinszky; Vo Van Giau; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-14       Impact factor: 2.570

3.  Transmission of CJD from nasal brushings but not spinal fluid or RT-QuIC product.

Authors:  Gregory J Raymond; Brent Race; Christina D Orrú; Lynne D Raymond; Matilde Bongianni; Michele Fiorini; Bradley R Groveman; Sergio Ferrari; Luca Sacchetto; Andrew G Hughson; Salvatore Monaco; Maurizio Pocchiari; Gianluigi Zanusso; Byron Caughey
Journal:  Ann Clin Transl Neurol       Date:  2020-06-15       Impact factor: 4.511

Review 4.  Transmissibility versus Pathogenicity of Self-Propagating Protein Aggregates.

Authors:  Byron Caughey; Allison Kraus
Journal:  Viruses       Date:  2019-11-09       Impact factor: 5.048

Review 5.  Prion protein-Semisynthetic prion protein (PrP) variants with posttranslational modifications.

Authors:  Stefanie Hackl; Christian F W Becker
Journal:  J Pept Sci       Date:  2019-10       Impact factor: 1.905

Review 6.  Defining the Protein Seeds of Neurodegeneration using Real-Time Quaking-Induced Conversion Assays.

Authors:  Matteo Manca; Allison Kraus
Journal:  Biomolecules       Date:  2020-08-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.